Plasma membrane monoamine transporters: structure, regulation and function, Nat Rev Neurosci, vol.4, pp.13-25, 2003. ,
Neurotransmitter transporters and their impact on the development of psychopharmacology, Br J Pharmacol, vol.147, issue.1, pp.82-88, 2006. ,
Monoamine dysfunction and the pathophysiology and treatment of depression, J Clin Psychiatry, vol.59, pp.11-14, 1998. ,
The cellular neurobiology of depression, Nat Med, vol.7, pp.541-547, 2001. ,
Characterization of extracellular dopamine clearance in the medial prefrontal cortex: role of monoamine uptake and monoamine oxidase inhibition, J Neurosci, vol.21, pp.35-44, 2001. ,
Uptake and release of norepinephrine by serotonergic terminals in norepinephrine transporter knock-out mice: implications for the action of selective serotonin reuptake inhibitors, J Neurosci, vol.24, pp.7888-7894, 2004. ,
Transport mechanisms governing serotonin clearance in vivo revealed by high-speed chronoamperometry, J Neurosci Methods, vol.143, pp.49-62, 2005. ,
Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter, Nat Neurosci, vol.1, pp.349-351, 1998. ,
Organic cation transporter 3 (Slc22a3) is implicated in salt-intake regulation, J Neurosci, vol.24, pp.2846-2851, 2004. ,
URL : https://hal.archives-ouvertes.fr/inserm-02008093
Differential pharmacological in vitro properties of organic cation transporters and regional distribution in rat brain, Neuropharmacology, vol.50, pp.941-952, 2006. ,
Identification and characterization of a novel monoamine transporter in the human brain, J Biol Chem, vol.279, pp.50042-50049, 2004. ,
Impaired activity of the extraneuronal monoamine transporter system known as uptake-2 in Orct3/Slc22a3-deficient mice, Mol Cell Biol, vol.21, pp.4188-4196, 2001. ,
Deficiency in the organic cation transporters 1 and 2 (Oct1/Oct2 [Slc22a1/Slc22a2]) in mice abolishes renal secretion of organic cations, Mol Cell Biol, vol.23, pp.7902-7908, 2003. ,
Altered aminergic neurotransmission in the brain of organic cation transporter 3-deficient mice, J Neurochem, vol.106, pp.1471-1482, 2008. ,
URL : https://hal.archives-ouvertes.fr/inserm-02008107
Organic cation transporter 3: keeping the brake on extracellular serotonin in serotonin-transporter-deficient mice, Proc Natl Acad Sci, vol.105, pp.18976-18981, 2008. ,
The organic cation transporter-3 is a pivotal modulator of neurodegeneration in the nigrostriatal dopaminergic pathway, Proc Natl Acad Sci, vol.106, pp.8043-8048, 2009. ,
Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine, Mol Pharmacol, vol.54, pp.342-352, 1998. ,
Isocyanines and pseudoisocyanines as a novel class of potent noradrenaline transport inhibitors: synthesis, detection, and biological activity, J Med Chem, vol.36, pp.4208-4213, 1993. ,
Homeostatic regulation of serotonergic function by the serotonin transporter as revealed by nonviral gene transfer, J Neurosci, vol.20, pp.5065-5075, 2000. ,
Electrophysiology of hippocampal neurons. I. Sequential invasion and synaptic organization, J Neurophysiol, vol.24, pp.225-242, 1961. ,
Effects of acute treatment with paroxetine, citalopram and venlafaxine in vivo on noradrenaline and serotonin outflow: a microdialysis study in Swiss mice, Br J Pharmacol, vol.140, pp.1128-1136, 2003. ,
Pharmacology and distribution of norepinephrine transporters in the human locus coeruleus and raphe nuclei, J Neurosci, vol.17, pp.1710-1719, 1997. ,
Regional distribution of 5-HT transporters in the brain of wild type and 'Purkinje cell degeneration' mutant mice: a quantitative autoradiographic study with [ 3 H]citalopram, J Chem Neuroanat, vol.15, pp.155-171, 1998. ,
Altered expression and functions of serotonin 5-HT1A and 5HT1B receptors in knock-out mice lacking the 5-HT transporter, Eur J Neurosci, vol.12, pp.2299-2310, 2000. ,
Efficacy of the MCHR1 antagonist N-[3-(1-{[4(3,4-difluorophenoxy)phenyl]methyl}(4-piperidyl))-4-methylphen yl]-2-methylpropanamide (SNAP 94847) in mouse models of anxiety and depression following acute and chronic administration is independent of hippocampal neurogenesis, J Pharmacol Exp Ther, vol.321, pp.237-248, 2007. ,
Depression: a new animal model sensitive to antidepressant treatments, Nature, vol.266, pp.730-732, 1977. ,
Neurogenesis-dependent and-independent effects of fluoxetine in an animal model of anxiety/depression, Neuron, vol.62, pp.479-493, 2009. ,
Emotion circuits in the brain, Annu Rev Neurosci, vol.23, pp.155-184, 2000. ,
Prefrontal cortical-amygdalar metabolism in major depression, Ann NY Acad Sci, vol.877, pp.614-637, 1999. ,
Neuroimaging studies of mood disorders, Biol Psychiatry, vol.48, pp.813-829, 2000. ,
Transport of monoamine transmitters by the organic cation transporter type 2, OCT2, J Biol Chem, vol.273, pp.30915-30920, 1998. ,
Modifications of the serotonergic system in mice lacking serotonin transporters: an in vivo electrophysiological study, J Pharmacol Exp Ther, vol.296, pp.987-995, 2001. ,
Regionally specific regulation of ERK MAP kinase in a model of antidepressant-sensitive chronic depression, Biol Psychiatry, vol.63, pp.353-359, 2008. ,
Quantitative evaluation of 5-hydroxytryptamine (serotonin) neuronal release and uptake: an investigation of extrasynaptic transmission, J Neurosci, vol.18, pp.4854-4860, 1998. ,
Catecholamine release and uptake in the mouse prefrontal cortex, J Neurochem, vol.79, pp.130-142, 2001. ,
In vivo dynamics of norepinephrine release-reuptake in multiple terminal field regions of rat brain, J Neurochem, vol.63, pp.917-926, 1994. ,
Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine ('Ecstasy') in serotonin transporter-deficient mice, Mol Pharmacol, vol.53, pp.649-655, 1998. ,
Mice lacking the norepinephrine transporter are supersensitive to psychostimulants, Nat Neurosci, vol.3, pp.465-471, 2000. ,
Neuroimaging studies of mood disorder effects on the brain, Biol Psychiatry, vol.54, pp.338-352, 2003. ,
Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells, Biol Psychiatry, vol.48, pp.766-777, 2000. ,
Deep brain stimulation for treatment-resistant depression, Neuron, vol.45, pp.651-660, 2005. ,
Catecholaminergic strategies for the treatment of major depression, Curr Drug Targets, vol.7, pp.149-158, 2006. ,
Cellular localization of the organic cation transporters, OCT1 and OCT2, in brain microvessel endothelial cells and its implication for MPTP transport across the blood-brain barrier and MPTP-induced dopaminergic toxicity in rodents, J Neurochem, vol.114, pp.717-727, 2010. ,
Circuitry underlying regulation of the serotonergic system by swim stress, J Neurosci, vol.23, pp.970-977, 2003. ,
Serotonin activates the hypothalamic-pituitary-adrenal axis via serotonin 2C receptor stimulation, J Neurosci, vol.27, pp.6956-6964, 2007. ,
Noradrenergic innervation of the dorsal medial prefrontal cortex modulates hypothalamopituitary-adrenal responses to acute emotional stress, J Neurosci, vol.28, pp.5806-5816, 2008. ,
Neural regulation of endocrine and autonomic stress responses, Nat Rev Neurosci, vol.10, pp.397-409, 2009. ,
Forced swim stress activates rat hippocampal serotonergic neurotransmission involving a corticotropin-releasing hormone receptor-dependent mechanism, Eur J Neurosci, vol.16, pp.2441-2452, 2002. ,
Norepinephrine release in medial amygdala facilitates activation of the hypothalamic-pituitary-adrenal axis in response to acute immobilisation stress, J Neuroendocrinol, vol.17, pp.22-28, 2005. ,
Enhanced hippocampal noradrenaline and serotonin release in galanin-overexpressing mice after repeated forced swimming test, Proc Natl Acad Sci, vol.101, pp.354-359, 2004. ,
The potent activity of the 5-HT1A receptor agonists, S 14506 and S 14671, in the rat forced swim test is blocked by novel 5-HT1A receptor antagonists, Eur J Pharmacol, vol.271, pp.537-541, 1994. ,
5-HT1A receptors are differentially involved in the anxiolytic-and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat, Eur Neuropsychopharmacol, vol.14, pp.487-495, 2004. ,
Comparative study of pre-and postsynaptic 5-HT1A receptor modulation of anxiety in two ethological animal tests, J Neurosci, vol.16, pp.4810-4815, 1996. ,
5-HT(1A) receptor function in major depressive disorder, Prog Neurobiol, vol.88, pp.17-31, 2009. ,
Reduction in the density and expression, but not G-protein coupling, of serotonin receptors (5-HT1A) in 5-HT transporter knock-out mice: gender and brain region differences, J Neurosci, vol.20, pp.7888-7895, 2000. ,
Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications, Pharm Res, vol.24, pp.1227-1251, 2007. ,
Role of somatodendritic 5-HT autoreceptors in modulating 5-HT neurotransmission, Ann NY Acad Sci, vol.861, pp.204-216, 1998. ,
Augmentation with a 5-HT(1A), but not a 5-HT(1B) receptor antagonist critically depends on the dose of citalopram, Eur J Pharmacol, vol.397, pp.63-74, 2000. ,
Blockade of the antidepressant-like effects of 8-OH-DPAT, buspirone and desipramine in the rat forced swim test by 5HT1A receptor antagonists, Psychopharmacology (Berl), vol.119, pp.47-54, 1995. ,
Drug-dependent requirement of hippocampal neurogenesis in a model of depression and of antidepressant reversal, Biol Psychiatry, vol.64, pp.293-301, 2008. ,
Reversal of hippocampal neuronal maturation by serotonergic antidepressants, Proc Natl Acad Sci, vol.107, pp.8434-8439, 2010. ,
Alpha2-adrenoceptor blockade accelerates the neurogenic, neurotrophic, and behavioral effects of chronic antidepressant treatment, J Neurosci, vol.30, pp.1096-1109, 2010. ,
5-HT1A autoreceptor levels determine vulnerability to stress and response to antidepressants, Neuron, vol.65, pp.40-52, 2010. ,
Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: I. in vivo electrophysiological studies in the rat, Neuropharmacology, vol.39, pp.1800-1812, 2000. ,
Effects of the selective norepinephrine reuptake inhibitor reboxetine on norepinephrine and serotonin transmission in the rat hippocampus, Neuropsychopharmacology, vol.25, pp.845-857, 2001. ,
In vivo effect of venlafaxine on locus coeruleus neurons: role of opioid, alpha(2)-adrenergic, and 5hydroxytryptamine(1A) receptors, J Pharmacol Exp Ther, vol.322, pp.101-107, 2007. ,